Kirin Holdings announced on June 14 that it will fully acquire FANCL, a company engaged in the cosmetics and health food business, through a public tender offer.

In 2019, Kirin acquired a 33 percent stake in FANCL. It plans to make FANCL a wholly-owned subsidiary through a public tender offer, spending approximately 220 billion yen and aiming to acquire 100 percent of the shares within the year.

Amid the shrinking domestic beer and beverage market, Kirin aims to expand its medicine, food and health science business by integrating FANCL’s cosmetics and health products.

This strategy is intended to grow both companies’ respective businesses.

Kirin aims to grow its health science business to a scale of 500 billion yen within 10 years, making it comparable to its beverage segment.